The conditions that make Chile an attractive hub for cancer commercial clinical trials are determined by an interplay of global, national, and community-level structural arrangements between public and private actors. Chile serves as an important global health case study on the role of the pharmaceutical industry in capitalizing on systemic healthcare failures to advance clinical research on metastatic cancer.
No takes yet. Share an insight, caveat, or question.
Fernández‐González et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: